Creative Biolabs-Immuno-oncology

Anti-DLG1 (clone DS9Q9Q5LAB) SynExpress C-Cy3-I10-K Modified CD8+ T cells (CAT#: ITS-1224-CR2098)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLG1 (clone DS9Q9Q5LAB). We employs the Retrovirus (CMV-Cy3-IL-10-KpnI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Rabbit
Target
DLG1
Clone
DS9Q9Q5LAB
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
IL-10
Insertion Sites
KpnI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
Retrovirus
Transformation Accuracy
0.89
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.